ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $289,078 | -3.0% | 80,748 | 0.0% | 0.00% | – |
Q2 2023 | $297,960 | +30.8% | 80,748 | +17.3% | 0.00% | – |
Q1 2023 | $227,778 | -14.7% | 68,815 | 0.0% | 0.00% | – |
Q4 2022 | $267,002 | +53.0% | 68,815 | -4.2% | 0.00% | – |
Q3 2022 | $174,547 | +19.2% | 71,830 | -2.9% | 0.00% | – |
Q2 2022 | $146,433 | -83.1% | 73,956 | +122.6% | 0.00% | -100.0% |
Q4 2020 | $865,000 | +871.9% | 33,218 | -11.0% | 0.00% | – |
Q3 2020 | $89,000 | -19.1% | 37,340 | 0.0% | 0.00% | – |
Q2 2020 | $110,000 | -4.3% | 37,340 | -6.8% | 0.00% | – |
Q1 2020 | $115,000 | -8.0% | 40,080 | +28.6% | 0.00% | – |
Q4 2019 | $125,000 | -12.0% | 31,172 | +2.0% | 0.00% | – |
Q3 2019 | $142,000 | – | 30,571 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |